SG11201403437TA - Ion exchange membrane chromatography - Google Patents

Ion exchange membrane chromatography

Info

Publication number
SG11201403437TA
SG11201403437TA SG11201403437TA SG11201403437TA SG11201403437TA SG 11201403437T A SG11201403437T A SG 11201403437TA SG 11201403437T A SG11201403437T A SG 11201403437TA SG 11201403437T A SG11201403437T A SG 11201403437TA SG 11201403437T A SG11201403437T A SG 11201403437TA
Authority
SG
Singapore
Prior art keywords
ion exchange
exchange membrane
membrane chromatography
chromatography
ion
Prior art date
Application number
SG11201403437TA
Other languages
English (en)
Inventor
Jerome Joseph Bill Jr
Arick Michael Brown
Christopher John Dowd
Brooke Ellen Thayer
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47430154&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201403437T(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of SG11201403437TA publication Critical patent/SG11201403437TA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/165—Extraction; Separation; Purification by chromatography mixed-mode chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
SG11201403437TA 2011-12-22 2012-12-18 Ion exchange membrane chromatography SG11201403437TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161579285P 2011-12-22 2011-12-22
PCT/US2012/070373 WO2013096322A1 (fr) 2011-12-22 2012-12-18 Chromatographie sur membrane échangeuse d'ions

Publications (1)

Publication Number Publication Date
SG11201403437TA true SG11201403437TA (en) 2014-07-30

Family

ID=47430154

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201403437TA SG11201403437TA (en) 2011-12-22 2012-12-18 Ion exchange membrane chromatography

Country Status (22)

Country Link
US (2) US10364268B2 (fr)
EP (2) EP3492486A1 (fr)
JP (5) JP6605202B2 (fr)
KR (3) KR20200008022A (fr)
CN (2) CN104125963B (fr)
AR (1) AR089362A1 (fr)
AU (3) AU2012355356B2 (fr)
BR (1) BR112014015101A8 (fr)
CA (1) CA2859376C (fr)
ES (1) ES2697676T3 (fr)
HK (1) HK1203526A1 (fr)
HR (1) HRP20181846T1 (fr)
IL (2) IL267585B (fr)
MX (2) MX360453B (fr)
MY (1) MY172426A (fr)
PL (1) PL2794635T3 (fr)
RU (1) RU2648999C2 (fr)
SG (1) SG11201403437TA (fr)
SI (1) SI2794635T1 (fr)
TR (1) TR201815709T4 (fr)
WO (1) WO2013096322A1 (fr)
ZA (2) ZA201404593B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201815709T4 (tr) * 2011-12-22 2018-11-21 Hoffmann La Roche İyon değişim membranı kromatografisi.
CN110054661A (zh) 2013-12-12 2019-07-26 Emd密理博公司 使用含丙烯酰胺的过滤器分离蛋白
TWI787590B (zh) * 2013-12-27 2022-12-21 日商中外製藥股份有限公司 等電點低之抗體的精製方法
CN104693303B (zh) * 2015-02-28 2018-03-13 苏州金盟生物技术有限公司 一种蛋白制品中的核酸去除方法
SG10202101105XA (en) 2015-08-13 2021-03-30 Amgen Inc Charged depth filtration of antigen-binding proteins
GB201711481D0 (en) 2017-07-17 2017-08-30 Ucb Biopharma Sprl Protein purification
EP3546475A1 (fr) * 2018-03-27 2019-10-02 Sanofi Processus d'écoulement intégral pour purifier des protéines recombinées
US10792618B2 (en) 2018-06-19 2020-10-06 Sartorius Stedim Biotech Gmbh Particle separation and/or purification of a fluid
GB201815405D0 (en) * 2018-09-21 2018-11-07 Fujifilm Mfg Europe Bv Membranes suitable for detecting, filtering and/or purifying biomolecules
WO2020128797A1 (fr) * 2018-12-21 2020-06-25 3M Innovative Properties Company Procédé d'essai d'un dispositif de chromatographie utilisé pour un échange d'ions
AR119264A1 (es) * 2019-06-05 2021-12-09 Genentech Inc Método para reutilización de cromatografía
US11416468B2 (en) * 2020-07-21 2022-08-16 International Business Machines Corporation Active-active system index management
CN116371011B (zh) * 2023-05-26 2023-08-18 湖南杰萃生物技术有限公司 一种从桑叶中提取黄酮和生物碱的方法

Family Cites Families (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE266710C (fr)
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
US4515893A (en) 1979-04-26 1985-05-07 Ortho Pharmaceutical Corporation Hybrid cell line for producing complement-fixing monoclonal antibody to human T cells
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
DD266710A3 (de) 1983-06-06 1989-04-12 Ve Forschungszentrum Biotechnologie Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
JPS6150925A (ja) * 1984-08-17 1986-03-13 Toray Ind Inc 抗原または抗体の精製方法
US4879231A (en) 1984-10-30 1989-11-07 Phillips Petroleum Company Transformation of yeasts of the genus pichia
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
US5091178A (en) 1986-02-21 1992-02-25 Oncogen Tumor therapy with biologically active anti-tumor antibodies
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
AU626008B2 (en) * 1987-10-23 1992-07-23 Schering Corporation Method of purifying protein
US5091313A (en) 1988-08-05 1992-02-25 Tanox Biosystems, Inc. Antigenic epitopes of IgE present on B cell but not basophil surface
US5720937A (en) 1988-01-12 1998-02-24 Genentech, Inc. In vivo tumor detection assay
DE68919361T2 (de) 1988-06-21 1995-05-24 Genentech Inc Therapeutische zusammensetzungen für die behandlung von myocard-infarkten.
DE68925971T2 (de) 1988-09-23 1996-09-05 Cetus Oncology Corp Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
JP2844346B2 (ja) * 1989-05-31 1999-01-06 昭 梶 新規ペプチドならびに新規ｄｎａ
EP0402226A1 (fr) 1989-06-06 1990-12-12 Institut National De La Recherche Agronomique Vecteurs de transformation de la levure yarrowia
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
CA2113813C (fr) 1991-08-14 2005-04-12 Paula M. Jardieu Variants d'immunoglobulines specifiques des recepteurs fc epsilon
JPH07501451A (ja) 1991-11-25 1995-02-16 エンゾン・インコーポレイテッド 多価抗原結合タンパク質
AU675929B2 (en) 1992-02-06 1997-02-27 Curis, Inc. Biosynthetic binding protein for cancer marker
MX9305070A (es) 1992-08-21 1994-04-29 Genentech Inc Compocicion farmaceutica que contiene un antagonista de lfa-1 para el tratamiento de transtornos o desordenes mediados por el lfa-1
US5736137A (en) 1992-11-13 1998-04-07 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
US5595721A (en) 1993-09-16 1997-01-21 Coulter Pharmaceutical, Inc. Radioimmunotherapy of lymphoma using anti-CD20
HU218159B (hu) * 1993-09-21 2000-06-28 Hemosol Inc. Kiszorításos kromatográfiás eljárás tisztított hemoglobintermék előállítására
WO1995016203A2 (fr) 1993-12-10 1995-06-15 Genentech, Inc. Procedes pour diagnostiquer des allergies et pour selectionner des agents therapeutiques antiallergiques
DK0739214T3 (da) 1994-01-18 1998-10-07 Genentech Inc Fremgangsmåde til behandling af parasitinfektionerunder anvendelse af IgE antagonister
WO1995023865A1 (fr) 1994-03-03 1995-09-08 Genentech, Inc. Anticorps monoclonaux anti-il-8 pour le traitement des troubles
US5534615A (en) 1994-04-25 1996-07-09 Genentech, Inc. Cardiac hypertrophy factor and uses therefor
IL117645A (en) 1995-03-30 2005-08-31 Genentech Inc Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
CA2222231A1 (fr) 1995-06-07 1996-12-19 Imclone Systems Incorporated Anticorps et fragments d'anticorps inhibant la croissance des tumeurs
EP1297847A3 (fr) 1996-01-23 2003-05-07 Genentech, Inc. Anticorps dirigé contre le CD18 dans l'ictus cérébral
WO1997027757A1 (fr) * 1996-01-31 1997-08-07 John Stephen Ayers Production d'une fraction enrichie en immunoglobulines a partir de solutions de proteines de petit lait
US7147851B1 (en) 1996-08-15 2006-12-12 Millennium Pharmaceuticals, Inc. Humanized immunoglobulin reactive with α4β7 integrin
IL130143A0 (en) 1996-11-27 2000-06-01 Genentech Inc Humanized anti-CD11a antibodies
EP0973804B1 (fr) 1997-04-07 2006-12-27 Genentech, Inc. Anticorps anti-vegf
PT1860187E (pt) 1997-05-15 2011-10-04 Genentech Inc Receptor apo-2
US6054293A (en) 1997-07-08 2000-04-25 The Regents Of The University Of California Semaphorin receptors
US6946129B1 (en) 1999-06-08 2005-09-20 Seattle Genetics, Inc. Recombinant anti-CD40 antibody and uses thereof
EP1189641B1 (fr) 1999-06-25 2009-07-29 Genentech, Inc. Anticorps anti-erbb2 humanises et traitement a l'aide de ces anticorps
IL149116A0 (en) 1999-10-29 2002-11-10 Genentech Inc Anti-prostate stem cell antigen (psca) antibody compositions and methods of use
US20020012982A1 (en) 2000-07-13 2002-01-31 Invitrogen Corporation Methods and compositions for rapid protein and peptide extraction and isolation using a lysis matrix
UA83458C2 (uk) 2000-09-18 2008-07-25 Байоджен Айдек Ма Інк. Виділений поліпептид baff-r (рецептор фактора активації в-клітин сімейства tnf)
US7321026B2 (en) 2001-06-27 2008-01-22 Skytech Technology Limited Framework-patched immunoglobulins
WO2003025156A2 (fr) 2001-09-18 2003-03-27 Affinium Pharmaceuticals, Inc. Procedes et appareils de purification
WO2003033656A2 (fr) 2001-10-16 2003-04-24 Exelixis, Inc. Proteines msrebp utilisees comme modificateurs de la voie srebp et leurs methodes d'utilisation
AU2002351495A1 (en) 2001-10-17 2003-04-28 Human Genome Sciences, Inc. Neutrokine-alpha and neutrokine-alpha splice variant
US20040093621A1 (en) 2001-12-25 2004-05-13 Kyowa Hakko Kogyo Co., Ltd Antibody composition which specifically binds to CD20
CA2476166C (fr) 2002-02-14 2011-11-15 Immunomedics, Inc. Anticorps anti-cd20 et proteines hybrides desdits anticorps, et methodes d'utilisation
SI1558648T1 (sl) 2002-10-17 2012-05-31 Genmab As Človeška monoklonalna protitelesa proti CD
DE60332957D1 (de) 2002-12-16 2010-07-22 Genentech Inc Immunoglobulinvarianten und deren verwendungen
CN1206240C (zh) * 2003-04-07 2005-06-15 中国科学院生态环境研究中心 高效离子交换膜色谱纯化卵黄蛋白原技术
WO2005000901A2 (fr) 2003-05-09 2005-01-06 Duke University Anticorps specifiques de cd20 et leurs methodes d'utilisation
AR044388A1 (es) 2003-05-20 2005-09-07 Applied Molecular Evolution Moleculas de union a cd20
AU2004263538B2 (en) 2003-08-08 2009-09-17 Immunomedics, Inc. Bispecific antibodies for inducing apoptosis of tumor and diseased cells
US8147832B2 (en) 2003-08-14 2012-04-03 Merck Patent Gmbh CD20-binding polypeptide compositions and methods
US20080274501A1 (en) * 2007-05-02 2008-11-06 Chenming Zhang Method of purifying acidic proteins expressed in plants
US9433922B2 (en) 2007-08-14 2016-09-06 Emd Millipore Corporation Media for membrane ion exchange chromatography based on polymeric primary amines, sorption device containing that media, and chromatography scheme and purification method using the same
CN101835791A (zh) 2007-10-26 2010-09-15 旭化成化学株式会社 蛋白质的提纯方法
RS53850B2 (sr) 2007-10-30 2018-07-31 Genentech Inc Pročišćavanje antitela hromatografijom izmene katjona
WO2009135656A1 (fr) 2008-05-06 2009-11-12 Lonza Biologics Plc. Procédé de purification d’anticorps à l’aide de la chromatographie de déplacement
HUE047316T2 (hu) 2008-08-14 2020-04-28 Genentech Inc Eljárások szennyezés eltávolítására indigén fehérjekiszorításos ioncserés membrán kromatográfia alkalmazásával
GB0816242D0 (en) 2008-09-05 2008-10-15 Immunobiology Ltd Method of purifying protien complexes
MX346115B (es) 2009-08-06 2017-03-08 Genentech Inc * Metodo para mejorar la eliminación de virus en la purificacion proteica.
US9428548B2 (en) * 2009-09-01 2016-08-30 Genentech, Inc. Enhanced protein purification through a modified protein A elution
ES2617777T5 (es) * 2010-04-23 2022-10-13 Hoffmann La Roche Producción de proteínas heteromultiméricas
ES2637613T5 (es) * 2010-05-25 2022-07-20 Hoffmann La Roche Procedimientos de purificación de polipéptidos
CA2850728A1 (fr) * 2011-10-03 2013-04-11 Sachem, Inc. Molecules zwitterions neutres en tant qu'agents de deplacement pour la chromatographie de deplacement par interaction hydrophobe
TR201815709T4 (tr) 2011-12-22 2018-11-21 Hoffmann La Roche İyon değişim membranı kromatografisi.
JP5731726B1 (ja) 2014-06-26 2015-06-10 楽天株式会社 情報処理装置、情報処理方法及び情報処理プログラム

Also Published As

Publication number Publication date
EP2794635B8 (fr) 2018-11-14
US11945837B2 (en) 2024-04-02
IL267585B (en) 2022-09-01
HRP20181846T1 (hr) 2018-12-28
MX2014007622A (es) 2014-09-22
PL2794635T3 (pl) 2019-02-28
NZ626949A (en) 2016-11-25
ZA201404593B (en) 2022-12-21
SI2794635T1 (sl) 2018-12-31
WO2013096322A8 (fr) 2018-09-13
CN108892706A (zh) 2018-11-27
AU2020201070A1 (en) 2020-03-05
IL267585A (en) 2019-08-29
JP7402011B2 (ja) 2023-12-20
JP2018109024A (ja) 2018-07-12
JP7359807B2 (ja) 2023-10-11
MX360453B (es) 2018-11-01
JP6605202B2 (ja) 2019-11-13
AU2018200194A1 (en) 2018-02-01
CA2859376A1 (fr) 2013-06-27
TR201815709T4 (tr) 2018-11-21
JP2021169454A (ja) 2021-10-28
ES2697676T3 (es) 2019-01-25
AU2012355356A1 (en) 2014-07-10
IL233158A0 (en) 2014-07-31
CN104125963A (zh) 2014-10-29
KR102067075B1 (ko) 2020-01-17
CA2859376C (fr) 2022-04-19
JP2022101557A (ja) 2022-07-06
EP2794635A1 (fr) 2014-10-29
EP3492486A1 (fr) 2019-06-05
US20200102346A1 (en) 2020-04-02
WO2013096322A1 (fr) 2013-06-27
EP2794635B1 (fr) 2018-09-12
BR112014015101A2 (pt) 2017-06-13
RU2648999C2 (ru) 2018-03-29
JP2015503524A (ja) 2015-02-02
AR089362A1 (es) 2014-08-20
MY172426A (en) 2019-11-25
MX2018013356A (es) 2020-09-14
CN104125963B (zh) 2018-08-17
KR20210025692A (ko) 2021-03-09
AU2018200194B2 (en) 2019-11-14
US10364268B2 (en) 2019-07-30
US20140348845A1 (en) 2014-11-27
IL233158B (en) 2019-07-31
BR112014015101A8 (pt) 2021-06-08
JP2020040952A (ja) 2020-03-19
KR20200008022A (ko) 2020-01-22
WO2013096322A9 (fr) 2013-08-22
ZA201903994B (en) 2023-12-20
RU2014130017A (ru) 2016-02-10
KR20140114834A (ko) 2014-09-29
AU2012355356B2 (en) 2017-10-12
HK1203526A1 (en) 2015-10-30

Similar Documents

Publication Publication Date Title
IL267585A (en) Ion exchange membrane chromatography
EP2798691A4 (fr) Humidificateur à membrane
EP2692782A4 (fr) Membrane échangeuse d'ions
EP2714250A4 (fr) Membranes
HK1217232A1 (zh) 離子强度介導的 梯度離子交換色譜
PL2734473T3 (pl) Związki typu granatu przewodzące jony litu
EP2667919A4 (fr) Humidificateur
GB201107849D0 (en) Cooperative positioning
IL238131B (en) Coated membranes for ion exchange
HK1214938A1 (zh) 分析輔件
EP2698839A4 (fr) Bloc de cellules
IL225720A0 (en) Antibody purification in one ion exchange chromatography unit
EP2665057A4 (fr) Système de spectacle
EP2711340A4 (fr) Équipement échangeur d'ions
EP2800229A4 (fr) Système de pile
EP2709203A4 (fr) Système cellulaire
EP2734659A4 (fr) Support de membranes échangeuses d'ions
GB201118288D0 (en) Ion-conducting membrane
SG10201701383VA (en) Methods for manufacturing ion exchange membranes
GB201109281D0 (en) Membrane
SG11201400765SA (en) Electrochemical processor alignment system
GB2499313B (en) Ion exchange
GB2494304B (en) Spacer
ZA201102777B (en) Spacer
GB201120948D0 (en) Flooring membrane